特布他林联合布地奈德雾化吸入对慢性阻塞性肺疾病急性加重期疗效及护理观察  

Clinical Observation and Nursing of Terbutaline Combined with Budesonide Aerosol Inhalation on Chronic Obstructive Pulmonary Disease with Acute Aggravating Period

作　　者：谢芳芳[1] 温连英[1] 

机构地区：[1]江西省赣州市人民医院,江西赣州341000

出　　处：《中国药业》2016年第23期92-94,共3页China Pharmaceuticals

摘　　要：目的探讨特布他林联合布地奈德雾化吸入治疗慢性阻塞性肺疾病(COPD)急性加重期的疗效及护理。方法将120例COPD急性加重期患者按随机数字表法分为对照组和观察组,各60例。对照组采用祛痰、解痉、控制感染、低流量吸氧等常规治疗和常规护理;观察组在此基础上给予特布他林和布地奈德雾化吸入,并行综合护理。观察两组患者治疗7 d后的疗效、症状与体征缓解时间和血气分析等。结果治疗后,观察组患者的症状与体征缓解时间明显短于对照组,差异有统计学意义(P<0.05);观察组患者的动脉血氧分压水平明显高于对照组,差异有统计学意义(P<0.05)。结论特布他林联合布地奈德雾化吸入辅以综合护理,可有效治疗COPD急性加重,值得临床推广。Objective To explore the clinical efficacy and nursing of terbutaline and budesonide aerosol inhalation on chronic obstructive pulmonary disease with acute aggravating period.M ethods 120 patients with COPD acute aggravating period were divided into the control group and the observation group in accordance with the random number table method,60 cases in each group.The control group was treated with the expectorant,spasmolysis,infection control,low flow oxygen therapy and other conventional treatment and conventional nursing;the observation group accepted terbutaline and budesonide aerosol inhalation in addition with comprehensive hospital care.Alter treatment,the clinical efficacy,signs of easing time and blood Qi analysis,etc.after 7 d treatment in the two groups were compared.Results After treatment,the time of ease of symptoms and signs in the observation group was obviously less than control group with significant difference（P〈0.05）.Retrial blood oxygen partial pressure of the observation group was significantly higher than that of control group with significant difference（P〈0.05）.Conclusion Terbutaline combined with budesonide aerosol inhalation is effective in treating COPD exacerbations,which is worthy of clinical promotion.

关 键 词：慢性阻塞性肺疾病 特布他林 布地奈德 疗效 护理 

分 类 号：R969.4[医药卫生—药理学] R974.3[医药卫生—药学]